Alnylam Pharmaceuticals (ALNY) Net Cash Flow (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.66% |
| Dec 31, 2025 | -54.56% |
| Sep 30, 2025 | 471.61% |
| Jun 30, 2025 | 67.19% |
| Mar 31, 2025 | 133.92% |
| Dec 31, 2024 | -200.31% |
| Sep 30, 2024 | -59.87% |
| Jun 30, 2024 | 340.88% |
| Mar 31, 2024 | 48.01% |
| Dec 31, 2023 | -160.56% |
| Sep 30, 2023 | 2,768.90% |
| Jun 30, 2023 | 92.71% |
| Mar 31, 2023 | 5.82% |
| Dec 31, 2022 | -142.06% |
| Sep 30, 2022 | 885.13% |
| Jun 30, 2022 | 117.74% |
| Mar 31, 2022 | -4.57% |
| Dec 31, 2021 | -177.16% |
| Sep 30, 2021 | -3.68% |
| Jun 30, 2021 | 422.62% |
| Mar 31, 2021 | -3,570.70% |
| Dec 31, 2020 | 96.43% |
| Sep 30, 2020 | -176.71% |
| Jun 30, 2020 | 243.06% |
| Mar 31, 2020 | 79.12% |
| Dec 31, 2019 | -76.42% |
| Sep 30, 2019 | -151.81% |
| Jun 30, 2019 | 35.02% |
| Mar 31, 2019 | 193.66% |
| Dec 31, 2018 | 332.69% |
| Sep 30, 2018 | -29.46% |
| Jun 30, 2018 | 86.15% |
| Mar 31, 2018 | -156.16% |
| Dec 31, 2017 | 314.55% |
| Sep 30, 2017 | -186.97% |
| Jun 30, 2017 | 1,154.18% |
| Mar 31, 2017 | -189.66% |
| Dec 31, 2016 | 124.50% |
| Sep 30, 2016 | -357.79% |
| Jun 30, 2016 | -21.01% |
| Mar 31, 2016 | 59.05% |
| Dec 31, 2015 | 1,649.76% |
| Sep 30, 2015 | 98.68% |
| Jun 30, 2015 | -167.12% |
| Mar 31, 2015 | 3,168.16% |
| Dec 31, 2014 | -478.23% |
| Sep 30, 2014 | 100.74% |
| Jun 30, 2014 | -190.73% |
| Mar 31, 2014 | 619.64% |
| Dec 31, 2013 | 414.65% |
| Sep 30, 2013 | 81.96% |
| Jun 30, 2013 | -256.96% |
| Mar 31, 2013 | 289.90% |
| Dec 31, 2012 | -188.64% |
| Sep 30, 2012 | 304.71% |
| Jun 30, 2012 | -58.62% |
| Mar 31, 2012 | -106.65% |
| Dec 31, 2011 | -156.85% |
| Sep 30, 2011 | 130.78% |
| Jun 30, 2011 | -246.83% |
| Mar 31, 2011 | -42.31% |
| Dec 31, 2010 | 243.61% |
| Sep 30, 2010 | 60.40% |
| Jun 30, 2010 | -116.40% |
| Mar 31, 2010 | -157.18% |
| Dec 31, 2009 | 179.12% |